News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
76,809 Results
Type
Article (2440)
Company Profile (17)
Press Release (74352)
Multimedia
Podcasts (2)
Webinars (1)
Section
Business (33052)
Career Advice (60)
Deals (4939)
Drug Delivery (5)
Drug Development (10705)
Employer Resources (10)
FDA (1713)
Job Trends (2275)
News (48517)
Policy (2946)
Tag
Academia (146)
Accelerated approval (1)
Allergies (15)
Alliances (2613)
ALS (35)
Alzheimer's disease (178)
Antibody-drug conjugate (ADC) (18)
Approvals (1776)
Artificial intelligence (22)
Autoimmune disease (6)
Automation (1)
Bankruptcy (20)
Best Places to Work (2179)
Biosimilars (8)
Biotechnology (11)
Bladder cancer (14)
Brain cancer (3)
Breast cancer (107)
Cancer (531)
Cardiovascular disease (45)
Career advice (54)
Career pathing (1)
CAR-T (12)
CDC (1)
Cell therapy (46)
Cervical cancer (6)
Clinical research (9819)
Collaboration (80)
Compensation (132)
Complete response letters (2)
COVID-19 (320)
CRISPR (5)
C-suite (19)
Cystic fibrosis (16)
Data (810)
Depression (6)
Diabetes (44)
Diagnostics (840)
Digital health (4)
Diversity, equity & inclusion (3)
Drug discovery (12)
Drug pricing (6)
Drug shortages (2)
Duchenne muscular dystrophy (27)
Earnings (30059)
Employer branding (2)
Employer resources (7)
Events (7963)
Executive appointments (26)
FDA (2175)
Frontotemporal dementia (3)
Funding (73)
Gene editing (9)
Generative AI (2)
Gene therapy (36)
GLP-1 (126)
Government (410)
Guidances (246)
Healthcare (2419)
HIV (9)
Huntington's disease (2)
IgA nephropathy (15)
Immunology and inflammation (24)
Immuno-oncology (1)
Indications (10)
Infectious disease (358)
Inflammatory bowel disease (29)
Inflation Reduction Act (1)
Influenza (17)
Intellectual property (11)
Interviews (8)
IPO (3557)
IRA (2)
Job creations (214)
Job search strategy (46)
Kidney cancer (3)
Labor market (14)
Layoffs (47)
Leadership (1)
Legal (437)
Liver cancer (7)
Longevity (3)
Lung cancer (126)
Lymphoma (54)
Machine learning (1)
Management (2)
Manufacturing (43)
MASH (25)
Medical device (1788)
Medtech (1790)
Mergers & acquisitions (1471)
Metabolic disorders (146)
Multiple sclerosis (43)
NASH (4)
Neurodegenerative disease (24)
Neuropsychiatric disorders (11)
Neuroscience (325)
NextGen: Class of 2025 (505)
Non-profit (412)
Now hiring (1)
Obesity (70)
Opinion (6)
Ovarian cancer (15)
Pain (20)
Pancreatic cancer (15)
Parkinson's disease (15)
Partnered (2)
Patents (21)
Patient recruitment (21)
Peanut (10)
People (2322)
Pharmaceutical (6)
Pharmacy benefit managers (1)
Phase I (2059)
Phase II (4033)
Phase III (4305)
Pipeline (1075)
Policy (9)
Postmarket research (462)
Preclinical (666)
Press Release (2)
Prostate cancer (20)
Psychedelics (2)
Radiopharmaceuticals (27)
Rare diseases (56)
Real estate (319)
Recruiting (4)
Regulatory (2442)
Reports (8)
Research institute (178)
Resumes & cover letters (4)
Rett syndrome (1)
RNA editing (1)
RSV (11)
Schizophrenia (18)
Series A (5)
Series B (8)
Sickle cell disease (8)
Special edition (2)
Spinal muscular atrophy (10)
Sponsored (2)
Startups (135)
Stomach cancer (2)
Supply chain (1)
Tariffs (2)
The Weekly (2)
Vaccines (81)
Venture capital (10)
Weight loss (32)
Women's health (3)
Worklife (1)
Date
Today (11)
Last 7 days (43)
Last 30 days (265)
Last 365 days (5050)
2025 (3870)
2024 (5482)
2023 (5967)
2022 (6930)
2021 (7305)
2020 (6468)
2019 (5112)
2018 (4070)
2017 (3616)
2016 (2700)
2015 (3644)
2014 (2403)
2013 (1632)
2012 (2188)
2011 (2376)
2010 (2146)
Location
Africa (47)
Alabama (15)
Arizona (17)
Arkansas (1)
Asia (3858)
Australia (391)
California (1325)
Canada (517)
China (113)
Colorado (73)
Connecticut (68)
Delaware (76)
Europe (10053)
Florida (177)
Georgia (47)
Idaho (6)
Illinois (76)
India (4)
Indiana (87)
Japan (58)
Kansas (10)
Kentucky (3)
Louisiana (5)
Maine (14)
Maryland (124)
Massachusetts (1012)
Michigan (33)
Minnesota (74)
Mississippi (1)
Missouri (11)
Montana (4)
Nebraska (2)
Nevada (11)
New Hampshire (9)
New Jersey (517)
New York (489)
North Carolina (158)
Northern California (720)
Ohio (28)
Oklahoma (1)
Oregon (3)
Pennsylvania (421)
Puerto Rico (1)
South America (100)
South Carolina (5)
Southern California (476)
Tennessee (11)
Texas (148)
United States (5148)
Utah (44)
Virginia (17)
Washington D.C. (17)
Washington State (137)
West Virginia (1)
Wisconsin (5)
76,809 Results for "48".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Government
Despite mRNA Vaccine Pullback, HHS Awards $48M for Kernal’s mRNA CAR T Program
The $48 million award, granted through the Advanced Research Projects Agency for Health, will help Kernal take its in vivo mRNA-encoded CAR T therapy forward.
October 8, 2025
·
2 min read
·
Tristan Manalac
Press Releases
bioAffinity Technologies Announces Pricing of $4.8 Million Public Offering
September 29, 2025
·
4 min read
Press Releases
Vir Biotechnology to Present Week 48 SOLSTICE Clinical Results in Hepatitis Delta at AASLD’s The Liver Meeting® 2025
October 8, 2025
·
3 min read
Press Releases
Thermo Fisher Scientific Expands Neurodegeneration Research Capabilities with Launch of Olink® Target 48 Neurodegeneration Panel
September 16, 2025
·
4 min read
Press Releases
Vor Bio Announces Oral Presentation of 48-Week China Phase 3 Generalized Myasthenia Gravis Clinical Study at AANEM
September 18, 2025
·
2 min read
China
Pharma Spent More Than $48B in China in H1, Eclipsing Total 2024 Haul
If the trend holds, IQVIA expects 2025 deal volume between Chinese and multinational companies to easily eclipse the 100 agreements signed in 2024.
August 27, 2025
·
2 min read
·
Annalee Armstrong
Press Releases
TREMFYA® (guselkumab) is first and only IL-23 inhibitor to demonstrate sustained clinical and endoscopic outcomes with a fully subcutaneous regimen through 48 weeks in ulcerative colitis
October 8, 2025
·
14 min read
Press Releases
Kernal Bio Awarded up to $48 Million from ARPA-H to Develop Lower Cost in vivo CAR T-cell Therapies for Hematological Cancers and Autoimmune Disease
October 7, 2025
·
4 min read
Press Releases
Advanced Wound Care Market Size to Reach USD 18.48 Billion By 2034
June 24, 2025
·
1 min read
Press Releases
Sionna Therapeutics to Present Preclinical Data During Oral Session at the 48th European Cystic Fibrosis Conference
May 22, 2025
·
2 min read
1 of 7,681
Next
